About the Authors

Steven G. Potkin

sgpotkin@uci.edu

Affiliation Department of Psychiatry and Human Behavior, University of California, Irvine, California, United States of America

Jean-Yves Loze

Affiliation Otsuka Pharmaceutical Europe Limited., Wexham, United Kingdom

Carlos Forray

Affiliation Lundbeck LLC, Paramus, New Jersey, United States of America

Ross A. Baker

Affiliation Otsuka Pharmaceutical Development & Commercialization, Inc., Princeton, New Jersey, United States of America

Christophe Sapin

Affiliation Lundbeck SAS, Issy-les-Moulineaux, France

Timothy Peters-Strickland

Affiliation Otsuka Pharmaceutical Development & Commercialization, Inc., Princeton, New Jersey, United States of America

Maud Beillat

Affiliation Lundbeck SAS, Issy-les-Moulineaux, France

Anna-Greta Nylander

Affiliation H. Lundbeck A/S, Valby, Denmark

Peter Hertel

Affiliation H. Lundbeck A/S, Valby, Denmark

Simon Nitschky Schmidt

Affiliation H. Lundbeck A/S, Valby, Denmark

Anders Ettrup

Affiliation H. Lundbeck A/S, Valby, Denmark

Anna Eramo

Affiliation Lundbeck LLC, Deerfield, Illinois, United States of America

Karina Hansen

Affiliation Lundbeck SAS, Issy-les-Moulineaux, France

Dieter Naber

Affiliation Department of Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf, Hamburg, Germany

Competing Interests

The authors declare the following conflicts of interest: Potkin SG has received grant support, funding, or honoraria or served as a consultant for the following companies that conducted scientific or medical research and/or marketed medications related to psychiatric and neurodegenerative disorders: Alkermes, Amgen, Baylor University, Eisai, Eli Lilly and Company, Forest, FORUM Pharmaceuticals, Lundbeck, Merck & Co., Inc., NIH, Novartis, Otsuka, Roche/Genentech, Sunovion Pharmaceuticals Inc., Takeda Pharmaceutical Company Ltd., Toyama, University of Southern California, UCSD, UCSF and Vanda Pharmaceuticals. Naber D: Advisory boards for Janssen/Cilag, Eli Lilly, Lundbeck, Otsuka and Servier; speaker honoraria from Astra Zeneca, Janssen/Cilag, Eli Lilly, Lundbeck and Otsuka. Loze JY: full-time employee of Otsuka Pharmaceutical Europe Ltd. Forray C, Sapin C, Beillat M, Nylander AG, Hertel P, Schmidt SN, Ettrup A, Eramo A, Hansen K: full-time employees of Lundbeck. Baker RA, Peters-Strickland T: full-time employees of Otsuka Pharmaceutical Development & Commercialization, Inc. Authors' employment by study sponsors does not alter our adherence to PLOS ONE policies on sharing data and materials.

Author Contributions

Conceptualization: SGP JYL CF RAB CS TP-S MB AGN PH SNS A. Ettrup A. Eramo KH DN. Data curation: SNS. Formal analysis: SNS. Funding acquisition: TP-S AGN. Investigation: A. Ettrup SNS. Methodology: A. Ettrup SNS. Project administration: A. Ettrup SNS. Resources: SNS. Software: SNS. Supervision: TP-S AGN. Validation: SNS. Visualization: A. Ettrup. Writing – original draft: A. Ettrup. Writing – review & editing: SGP JYL CF RAB CS TP-S MB AGN PH SNS A. Ettrup A. Eramo KH DN.